<DOC>
	<DOCNO>NCT02045290</DOCNO>
	<brief_summary>Insulin Clamp Ancillary study Assessment Insulin Resistance conduct sub-study main protocol , Metformin Therapy Overweight Adolescents With Type 1 Diabetes ( NCT01881828 ) . The purpose ancillary study ass metformin improve tissue-specific insulin resistance ( IR ) type 1 diabetes use hyperinsulinemic euglycemic clamp ; 3-month randomized trial compare metformin versus placebo 12 &lt; 20 year old BMI &gt; 85th percentile ( total daily insulin dose &gt; 0.7 units/kg , HbA1c 7.0 % -9.9 % ) .</brief_summary>
	<brief_title>Insulin Clamp Ancillary Study Assessment Insulin Resistance</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Meets eligibility criterion main study , Metformin Therapy Overweight Adolescents With Type 1 Diabetes ( NCT01881828 ) . 1 . Low hemoglobin hematocrit define local institution 's rule insulin clamp institutional requirement Hematocrit &lt; 30 % hemoglobin &lt; 10 gm/dL</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>